HBV-IN-10

• UNSPSC Description:

  HBV-IN-10 is an enantiomer of compound 6 (WO2021204258A1). Compound 6 is a hepatitis B surface antigen (HBsAg) inhibitor (0.001 μM50 ≤0.05 μM). From patent WO2021204258A1, compound 6[1].

• Target Antigen:

  HBV

• Type:

  Reference compound

• Related Pathways:

  Anti-infection

• Applications:

  COVID-19-anti-virus

• Field of Research:

  Infection

• Assay Protocol:

  https://www.medchemexpress.com/hbv-in-10.html

• Solubility:

  10 mM in DMSO

• Smiles:

  FC1=NC(N2[C@@]3([H])C4=CN=C(C5=NC=CC=N5)N=C4C[C@]2([H])CC3)=CC(N(CC6)CC6OC)=C1

• Molecular Weight:

  433.48

• References & Citations:

  [1]Azabicyclo compound as hepatitis b surface antigen inhibitor. WO2021204252A1.

• Shipping Conditions:

  Room temperature

• Clinical Information:

  No Development Reported

• CAS Number:

  2716907-16-1